Advertisement
Advertisement

IMNN

IMNN logo

Imunon, Inc. Common Stock

2.72
USD
Sponsored
-0.01
-0.37%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

2.75

+0.03
+1.29%

Imunon, Inc. Common Stock Profile

About

Imunon Inc. is a fully integrated, clinical stage biotechnology company. It focused on advancing a portfolio of treatments which harness the body's natural mechanisms. The company's lead clinical program includes GEN-1. Imunon Inc., formerly known as Celsion Corporation, is based in LAWRENCEVILLE, N.J.

Info & Links

CEO

Stacy Lindborg

Headquarters

997 LENOX DRIVE, SUITE 100
LAWRENCEVILLE, NJ 08648, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.imunon.com

Auditor

WithumSmith+Brown, PC

Share holders

85

Employees

20

Imunon, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

10.97M

Enterprise Value

2.19M

Enterprise Value/EBITDA(ttm)

-0.16

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-406.71%

Return on Invested Capital(ttm)

-1190.21%

Return on Assets(ttm)

-157.02%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-13.95M

Net Income Available to Common(ttm)

-14.50M

Diluted EPS(ttm)

-7.97

Share Statistics

Beta (5Y Monthly)

2.13

52-Week Change

-75.03%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

3.92M

Dividend Yield

0.00%

Float4

3.69M

% Held by Insiders

5.96%

% Held by Institutions

4.47%

Balance Sheet

Total Cash(mrq)

8.78M

Total Cash Per Share(mrq)

2.24

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.73%

Quick Ratio(mrq)

2.32%

Book Value Per Share(mrq)

1.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.48

Free Cash Flow(ytd)

-10.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement